Literature DB >> 4840433

Antibiotic susceptibility of Streptococcus bovis and other group D streptococci causing endocarditis.

C Thornsberry, C N Baker, R R Facklam.   

Abstract

Seventy-four strains of Streptococcus bovis and 35 strains of enterococci (Streptococcus faecalis and its varieties, Streptococcus faecium and Streptococcus durans), most of which were isolated from patients with endocarditis, were tested for their susceptibility to penicillin, ampicillin, erythromycin, cephalothin, vancomycin, methicillin, tetracycline, chloramphenicol, kanamycin, streptomycin, and gentamicin. Minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) were determined by a microtiter broth dilution technique. All of these organisms are group D streptococci, but the S. bovis strains are not enterococci. On the basis of both MIC and MBC, the S. bovis strains were much more susceptibile in general to antibiotics then were the enterococcal strains. For the S. bovis strains, the lowest MICs were obtained with penicillin, ampicillin, and erythromycin, and the lowest MBCs with penicillin and ampicillin. Although these antibiotics were also the most active against the enterococci, the MICs and MBCs were much higher than obtained with the S. bovis strains. Gentamicin was the most active aminoglycoside. On the basis of in vitro susceptibility results, the S. bovis strains resemble the viridans streptococci rather than enterococci.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4840433      PMCID: PMC428953          DOI: 10.1128/AAC.5.3.228

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

Review 1.  THE GROUP D STREPTOCOCCI.

Authors:  R H DEIBEL
Journal:  Bacteriol Rev       Date:  1964-09

2.  Penicillin and gentamicin therapy for enterococcal infections.

Authors:  A J Weinstein; R C Moellering
Journal:  JAMA       Date:  1973-02-26       Impact factor: 56.272

3.  Taxonomy of enterococci by computer analysis.

Authors:  H Raj; R R Colwell
Journal:  Can J Microbiol       Date:  1966-04       Impact factor: 2.419

4.  In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration.

Authors:  J A Washington; P E Hermans; W J Martin
Journal:  Mayo Clin Proc       Date:  1970-07       Impact factor: 7.616

5.  Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations.

Authors:  C J Wilkowske; R R Facklam; J A Washington; J E Geraci
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  A numerical taxonomic study of streptococci of serological group D.

Authors:  D Jones; M J Sackin; P H Sneath
Journal:  J Gen Microbiol       Date:  1972-10

7.  Rheumatic fever chemoprophylaxis and penicillin-resistant gingival organisms.

Authors:  W H Spencer; C Thornsberry; M D Moody; N K Wenger
Journal:  Ann Intern Med       Date:  1970-11       Impact factor: 25.391

8.  Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences.

Authors:  P Toala; A McDonald; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

9.  Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1972-06

10.  Infective endocarditis: past, present and future.

Authors:  L Weinstein
Journal:  J R Coll Physicians Lond       Date:  1972-01
View more
  21 in total

1.  Drug resistance in group D streptococci of clinical and nonclinical origin: prevalence, transferability, and plasmid properties.

Authors:  J D van Embden; H W Engel; B van Klingeren
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

2.  An analysis of group D streptococci recovered from cancer patients.

Authors:  V M Young; M J Morris; M R Moody; S C Schimpff; J W Gerster; P H Wiernik
Journal:  Infection       Date:  1978       Impact factor: 3.553

3.  Antibiotic susceptibility of clinical isolates of Listeria monocytogenes.

Authors:  G L Wiggins; W L Albritton; J C Feeley
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

4.  Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

5.  Presumptive identification of group A, B, and D streptococci on agar plate media.

Authors:  R R Facklam; J F Padula; E C Wortham; R C Cooksey; H A Rountree
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

6.  Rapid identification of enterococci.

Authors:  G S Bosley; R R Facklam; D Grossman
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

7.  Inhibition of Lancefield group D enterococci by contamination of a commercial identification medium with paraffins.

Authors:  J Butts; C Dees
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

8.  Enumeration and speciation of group D streptococci from above and below a sewer outfall, their susceptibilities to six antibiotics and a comparison with clinical isolates.

Authors:  S Bayne; M Blankson; D Thirkell
Journal:  Antonie Van Leeuwenhoek       Date:  1983-11       Impact factor: 2.271

9.  Presumptive identification of streptococci with a new test system.

Authors:  R R Facklam; L G Thacker; B Fox; L Eriquez
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

10.  Endocarditis due to a penicillin-tolerant streptococcus bovis: microbiological findings and echocardiographic follow-up.

Authors:  H Mittermayer; H J Nesser; W Ohlinger
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.